The disutility of chronic gout

Quality of Life Research

Volumn 17, Issue 5, 2008, Pages 815-822

  Khanna, Dinesh ^a,b   Ahmed, Mansoor ^c   Yontz, Dustin ^c   Ginsburg, Shaari S ^c   Park, Grace S ^a   Leonard, Anthony ^d   Tsevat, Joel ^c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gout; Health status; Health utility; Health related quality of life; Preference based measures

Indexed keywords

ALLOPURINOL; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; STATISTICAL SIGNIFICANCE;

ACTIVITIES OF DAILY LIVING; AGED; CHRONIC DISEASE; FEMALE; GOUT; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OHIO; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 49949152075     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-008-9355-0     Document Type: Article

References (31)

1. Saag, K. G., & Choi, H. (2006). Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Research & Therapy, 8(Suppl 1), S2.
2. Terkeltaub, R. A. (2003). Clinical practice. Gout. The New England Journal of Medicine, 349(17), 1647-1655.
3. Roddy, E., Zhang, W., & Doherty, M. (2007). Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford), 46(9), 1441-1444.
4. Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473-483.
5. Khanna, D., & Tsevat, J. (2007). Health-related quality of life-an introduction. The American Journal of Managed Care, 13(Suppl 9), S218-S223.
6. Kopec, J. A., & Willison, K. D. (2003). A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology, 56(4), 317-325.
7. Ware, J. E. J., Kosinki, M., & Keller, S. (1994). SF-36 Physical and mental health summary scales: A user's manual. Boston, Mass: Health Institute, New England Medical Center.
8. Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980). Measurement of patient outcome in arthritis. Arthritis and Rheumatism, 23(2), 137-145.
9. Torrance, G. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5, 1-30.
10. Von Neumann, J., & Morgenstern, O. (1953). Theory of games and economic behavior. New York: Wiley.
11. Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences-II: Scaling methods. Journal of Clinical Epidemiology, 42(5), 459-471.
12. Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998). Deriving a preference-based single index from the UK SF-36 Health Survey. Journal of Clinical Epidemiology, 51(11), 1115-1128.
13. The EuroQol Group (1990) EuroQol - a new facility for the measurement of health-related quality of life. Health Policy, 16(3):199-208.
14. Hirsch, J., Lee, S., Terkeltaub, R., Khanna, D., Singh, J., Sarkin, A., et al. (2006). Evaluation of the psychometric properties of a gout-specific patient reported outcomes (PRO) instrument. Arthritis Rheumatism, 54(9), S102 (Abstract).
15. Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., McCarty, D. J., & Yu, T. F. (1977). Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheumatism, 20(3), 895-900.
16. Ware, J., Kosinski, M., & Dewey, J. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric Incorporated.
17. UMaker user's manual (1999). UMDNJ technical report.
18. Arias, E. (2004). United States life tables, 2002. National Vital Statistics Reports, 53(6), 1-38.
19. Stalmeier, P. F., Goldstein, M. K., Holmes, A. M., Lenert, L., Miyamoto, J., Stiggelbout, A. M., et al. (2001). What should be reported in a methods section on utility assessment? Medical Decision Making, 21(3), 200-207.
20. Torrance, G. W. (1987). Utility approach to measuring health-related quality of life. Journal of Chronic Diseases, 40(6), 593-603.
21. Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998). Deriving a preference-based single index from the UK SF-36 Health Survey. Journal of Clinical Epidemiology, 51(11), 1115-1128.
22. Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271-92.
23. Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203-220.
24. Colton, T. (1974), Statistics in medicine. Boston: Little, Brown and Company.
25. Spencer, A. (2004). The implications of linking questions within the SG and TTO methods. Health Economics, 13(8), 807-818.
26. Stalmeier, P. F. (2002). Discrepancies between chained and classic utilities induced by anchoring with occasional adjustments. Medical Decision Making, 22(1), 53-64.
27. Hanmer, J., Lawrence, W. F., Anderson, J. P., Kaplan, R. M., & Fryback, D. G. (2006). Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Medical Decision Making, 26(4), 391-400.
28. Marra, C. A., Esdaile, J. M., Guh, D., Kopec, J. A., Brazier, J. E., Koehler, B. E., et al. (2004). A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Medical Care, 42(11), 1125-1131.
29. Bharmal, M., & Thomas, J. III (2006). Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health, 9(4), 262-71.
30. Hays, R. D. (2005). Reliability and validity (including responsiveness). In P. Fayers & R. D. Hays (Eds.), Assessing quality of life in clinical trials (2nd ed., pp. 25-39). New York: Oxford.
31. Khanna, D., Ahmed, M., Yontz, D., Ginsburg, S. S., & Tsevat, J. Willingness to pay for a cure in patients with chronic gout. Medical Decision Making 2008. Mar 18; [Epub ahead of print].